MYCRONIC AB (1MYCR.MI) Forecast, Price Target & Analyst Ratings

BIT:1MYCR • SE0025158629

Current stock price

25.16 EUR
+5.79 (+29.86%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MYCRONIC AB (1MYCR.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€21.21
-15.68% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 14, 2026
Period
Q1 / 2026
EPS Estimate
SEK3.82
Revenue Estimate
2.44B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€21.21
Upside
-15.68%
From current price of €25.16 to mean target of €21.21, Based on 11 analyst forecasts
Low
€13.49
Median
€22.55
High
€25.07

Price Target Revisions

1 Month
1.98%
3 Months
-8.15%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for 1MYCR.MI. The average price target is 21.22 EUR. This implies a price decrease of -15.68% is expected in the next year compared to the current price of 25.16.
The average price target has been revised downward by 8.15% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

1MYCR Current Analyst Rating1MYCR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

1MYCR Historical Analyst Ratings1MYCR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
1MYCR.MI was analyzed by 11 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about 1MYCR.MI.
In the previous month the buy percentage consensus was at a similar level.
1MYCR.MI was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 14, 2026
Period
Q1 / 2026
EPS Estimate
SEK3.82
Revenue Estimate
2.44B
Revenue Q2Q
13.91%
EPS Q2Q
20.39%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
1.46%
Revenue (3 Months)
N/A
EPS (1 Month)
3.62%
EPS (3 Months)
N/A

Next Earnings Summary

1MYCR.MI is expected to report earnings on 7/14/2026. The consensus EPS estimate for the next earnings is 3.82 EUR and the consensus revenue estimate is 2.44B EUR.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
1MYCR.MI revenue by date.1MYCR.MI revenue by date.
5.706B
11.47%		7.057B
23.68%		7.938B
12.48%		8.337B
5.03%		9.055B
8.61%		11.531B
27.34%
EBITDA
YoY % growth
1MYCR.MI ebitda by date.1MYCR.MI ebitda by date.
1.515B
36.24%		2.294B
51.42%		2.418B
5.41%		2.459B
1.70%		2.78B
13.05%		2.949B
6.08%
EBIT
YoY % growth
1MYCR.MI ebit by date.1MYCR.MI ebit by date.
1.251B
45.63%		2.028B
62.11%		2.088B
2.96%		2.041B
-2.25%		2.203B
7.94%		2.464B
11.85%
Operating Margin
1MYCR.MI operating margin by date.1MYCR.MI operating margin by date.
21.92%28.74%26.30%24.48%24.33%21.37%
EPS
YoY % growth
1MYCR.MI eps by date.1MYCR.MI eps by date.
5.11
34.47%		8.62
68.69%		7.99
-7.37%		8.50
6.41%		9.46
11.28%		10.69
13.03%

All data in SEK

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		3.82
20.39%		1.87
-18.13%		1.43
28.42%		1.60
12.54%
Revenue
Q2Q % growth		2.44B
13.91%		1.971B
-4.60%		1.829B
7.02%		2.074B
2.62%
EBITDA
Q2Q % growth		1.129B
23.12%		674.22M
5.76%		452.88M
36.07%		524.79M
16.49%
EBIT
Q2Q % growth		914.25M
17.51%		455.49M
-20.37%		322.14M
22.02%		363.49M
-0.41%

All data in SEK

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

1MYCR.MI Yearly Revenue VS Estimates1MYCR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
1MYCR.MI Yearly EPS VS Estimates1MYCR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.20%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
13.09%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
13.00%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MYCRONIC AB / 1MYCR.MI Forecast FAQ

What do analysts expect the price target to be for MYCRONIC AB (1MYCR.MI)?

11 analysts have analysed 1MYCR.MI and the average price target is 21.22 EUR. This implies a price decrease of -15.68% is expected in the next year compared to the current price of 25.16.

Can you provide the upcoming earnings date for MYCRONIC AB?

MYCRONIC AB (1MYCR.MI) will report earnings on 2026-07-14.

Can you provide the consensus estimates for MYCRONIC AB next earnings?

The consensus EPS estimate for the next earnings of MYCRONIC AB (1MYCR.MI) is 3.82 EUR and the consensus revenue estimate is 2.44B EUR.

How many analysts have analysed MYCRONIC AB (1MYCR.MI)?

The number of analysts covering MYCRONIC AB (1MYCR.MI) is 11.